GRANULOMATOUS SLACK SKIN - REPORT OF 3 PATIENTS WITH AN UPDATED REVIEW OF THE LITERATURE

Citation
Cw. Vanhaselen et al., GRANULOMATOUS SLACK SKIN - REPORT OF 3 PATIENTS WITH AN UPDATED REVIEW OF THE LITERATURE, Dermatology, 196(4), 1998, pp. 382-391
Citations number
46
Categorie Soggetti
Dermatology & Venereal Diseases
Journal title
ISSN journal
10188665
Volume
196
Issue
4
Year of publication
1998
Pages
382 - 391
Database
ISI
SICI code
1018-8665(1998)196:4<382:GSS-RO>2.0.ZU;2-1
Abstract
Purpose: Granulomatous slack skin (GSS) is a rare cutaneous disorder c haracterized clinically by the evolution of circumscribed erythematous lax skin masses, especially in the body folds, and histologically by a granulomatous T-cell infiltrate and loss of elastic fibers. GSS is o ften associated with preceding or subsequent lymphoproliferative malig nancies, especially mycosis fungoides (MF) and Hodgkin's disease (HD). No effective treatment is known yet. Whether this entity is a benign disorder, a peculiar host reaction to a malignant lymphoma, a precurso r of malignant lymphoma or an indolent cutaneous T-cell lymphoma (CTCL ) in itself is still a matter of debate. Patients and Methods: The res ults of the patients with GSS from the Netherlands are compared with t he cases reported in the world literature. Results: A female patient h ad had GSS for 8 years without developing a secondary malignancy. In a second female patient with a histologically confirmed diagnosis of ME GSS developed 18 years later in the axillary and inguinal folds which had previously been affected by plaque-stage MF lesions. A third male patient with a 6-year history of erythematosquamous skin disease diag nosed as CTCL developed GSS. Moreover, granuloma formation was also fo und in a facial basal cell carcinoma, in a cervical lymph node and the spleen. Clonal rearrangements of the T-cell receptor beta genes were found in the 2 female patients; the male patient could not be tested. Conclusion: GSS is a rare clinicopathological entity. Only 34 patients have been described so far. The development of GSS within plaque MF l esions has not been reported before. Our third case developed very ext ensive skin lesions and showed a strong propensity to develop granulom as as compared to cases reported before. The presence of a clonal T-ce ll population was demonstrated in all cases tested. Our cases support the idea that GSS is a very rare and rather indolent type of CTCL. App arently, the disease is associated with a peculiar immune response, ch aracterized by granuloma formation and disappearance of elastic fibers resulting in the lax skin. The relationship between GSS and other pre existing or subsequent lymphoproliferative diseases (diagnosed in appr oximately 50% of the cases) warrants a life-long follow-up.